Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Alzheimer's disease (AD) and age-related macular degeneration (AMD) are both neurodegenerative disorders which share common pathological and biochemical features of the complement pathway. The aim of this study was to investigate whether there is an association between well replicated AMD genetic risk factors and AD. A large cohort of AD (n = 3898) patients and controls were genotyped for single nucleotide polymorphisms (SNPs) in the complement factor H (CFH), the Age-related maculopathy susceptibility protein 2 (ARMS2) the complement component 2 (C2), the complement factor B (CFB), and the complement component 3 (C3) genes. While significant but modest associations were identified between the complement factor H, the age-related maculopathy susceptibility protein 2, and the complement component 3 single nucleotide polymorphisms and AD, these were different in direction or genetic model to that observed in AMD. In addition the multilocus genetic model that predicts around a half of the sibling risk for AMD does not predict risk for AD. Our study provides further support to the hypothesis that while activation of the alternative complement pathway is central to AMD pathogenesis, it is less involved in AD.

Original publication

DOI

10.1016/j.neurobiolaging.2011.12.036

Type

Journal article

Journal

Neurobiol Aging

Publication Date

08/2012

Volume

33

Pages

1843.e9 - 1843.17

Keywords

Aged, Aged, 80 and over, Alzheimer Disease, Comorbidity, Complement Pathway, Classical, Complement System Proteins, Europe, Female, Genetic Markers, Genetic Predisposition to Disease, Genetic Variation, Humans, Macular Degeneration, Male, Middle Aged, Polymorphism, Single Nucleotide, Prevalence, Risk Assessment